	Cross-population metabolome-wide Mendelian randomization study of prostate cancer risk. Res Sq Fuller H, Rohde R, Highland HM, Haessler J, Wu L, Graff M, Platz EA, Alkis T, Yu B, Boerwinkle E, Grove M, Kooperberg C, Peters U, North KE, Conti DV, Haiman CA, Young KL, Graff RE, Darst BF. PMID: 42245788 [PubMed]
	Detection of microplastics in bladder wash fluid obtained after cystoscopy in patients diagnosed with bladder cancer. Front Public Health Y, Ataman M, Tuna A. PMID: 42245347 [PubMed - in process]
	Validation, implementation, and impact of an AI model in routine practice for pathologic diagnosis of prostate cancer in an academic medical center. J Pathol Inform Udoh AI, Eyzaguirre E, Muthukumarana V, Thaker HM. PMID: 42245328 [PubMed]
	Therapeutic pressure drives the evolution of a protective ecotype characterized by AR-loss-induced senescence in prostate cancer. Theranostics He L, Jiang J, Liu S, Song H, Lu T, Hu Z, Li Y, Zhu H, Zhou Y, Li Z, Yang F, Zhang K, Zhang R, Wu T, Gan K, Zhao B, Zhang J, Si D, Zhang R, Shi C, Wen W, Han D, Xu C, Qin W. PMID: 42244988 [PubMed - in process]
	Comparative outcomes of focal HIFU versus active surveillance in low- and intermediate-risk localized prostate cancer: a 75-month retrospective cohort study. Front Urol Jaabou M, Buscarini M, Zaytoun O, Dovey Z, Hildebrand B, Awan M, Bada M, Al Ogaili M, Rabie A. PMID: 42244908 [PubMed]
	The Research Progress of Tumor-Associated Macrophages in Prostate Cancer. J Immunol Res Shen S, Tang Z, Guo C, Chen A, Mi Y. PMID: 42244152 [PubMed - in process]
	Integrative Transcriptomic Signature of tRNA-Derived Fragment Targets and Lactylation-Related Genes for Prostate Cancer Diagnosis. Cancer Med Wang L, Hu X, Wang B, Zhang Y, Yang J, Wang Y. PMID: 42244032 [PubMed - in process]
	Skin cancer mortality in Australian and New Zealand kidney transplant recipients: A population-based cohort study using linked health data, 1990-2019. Br J Dermatol Forcey DS, Rosales BM, Wyld ML, De La Mata N, Khosrotehrani K, Webster AC. PMID: 42243641 [PubMed - as supplied by publisher]
	Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial. J Pharmacokinet Pharmacodyn Wang Y, Hadigol M, Lincha VR, Hoffman J, Azad AA, Agarwal N, Matsubara N, Zohren F, DeAnnuntis L, Wang DD. PMID: 42243460 [PubMed - in process]
	Development of ultrasonography for the detection of prostate cancer. J Med Ultrason (2001) Kuroda S, Yuzuriha S, Takahashi K, Naruse J, Nakajima N, Shoji S. PMID: 42243380 [PubMed - as supplied by publisher]
	Improved Shared Decision-making for Patients with Renal Cell Carcinoma: Results of the SDM-RCC Study. Eur Urol Oncol Bresser CC, Garvelink MM, van Dijk T, van der Linde N, van den Berg BMM, Dolk FCK, van Melick HHE, van der Nat PB, SDM-RCC Study Group. PMID: 42242942 [PubMed - as supplied by publisher]
	Doublet Versus Triplet Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer Patients with Bone Metastases: Results from the ARON-3 Study. Eur Urol Oncol Mandel PC, Wenzel M, Gandur Quiroga MN, Bourlon MT, Chun F, Myint ZW, Bernal L, Kopp RM, Juan Fita MJ, Büttner T, Fiala O, Li H, Bögemann M, Buchler T, Matthews D, Rizzo A, Ciccimarra F, Marques Monteiro FS, Soares A, Massari F, Steuber T, Santoni M. PMID: 42242941 [PubMed - as supplied by publisher]
	Reply to Selcuk Guven, Selim Soyturk, and Thomas Herrmann's Letter to the Editor re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol 2026;86:111-15: My Vision for the Novel Transurethral Robotic Platform. Eur Urol Oncol Teoh JY. PMID: 42242940 [PubMed - as supplied by publisher]
	Sequential Imaging of Suspicion of Prostate Cancer: Reducing Overdiagnosis and Unnecessary Biopsy with Timely Diagnosis of Significant Cancer (SPROUT)-Prospective Multicentre Cohort Study Protocol. Eur Urol Oncol Sweere V, de Rooij M, Kil PJM, Israel B, van Basten JPA, Boellaard TN, Graus SA, van der Heijden AG, van der Hoeven EJRJ, Klaver OS, Mertens LS, Prette JF, Roelofs LAJ, Sedelaar JPM, Snoek AM, Somford DM, Barentsz JO, Van Melick HHE, van den Bergh RCN. PMID: 42242939 [PubMed - as supplied by publisher]
	Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing (68)Ga-PSMA PET/CT. J Nucl Med Jia KY, Kuten J, Jia HY, Bent EH, Silveira P, Pasquini L, Nalavenkata S, Schoder H, Fox JJ, Yeh R, Razmaria AA. PMID: 42242869 [PubMed - as supplied by publisher]
	Transition Zone PSA Density Does Not Improve Detection of Clinically Significant Prostate Cancer Over Whole-Gland PSAD: A Volume-Stratified Analysis in 3,958 Patients. Urol Int Behnel N, Engelage L, Lumiani A, Buchner A, Stadelmeier LF, Sroka R, Tamalunas A. PMID: 42241366 [PubMed - as supplied by publisher]
	Diagnostic Value of PSMA-PET/CT for the Detection of Pelvic Lymph Node Metastasis in Intermediate and High-Risk Prostate Cancer. Urol Int Albarghouth MH, Leeder M, Leucht K, Seifert P, Freesmeyer M, Hakenberg OW, Grimm MO. PMID: 42241365 [PubMed - as supplied by publisher]
	Intravoxel incoherent motion diffusion-weighted imaging for early response stratification of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor in renal cell carcinoma: an exploratory study. Jpn J Radiol Kang H, Zhao J, Ding X, Li S, Xie L, Yu M, Wen X, Zhou S, Bai X, Wang Y, Liang Q, Peng C, Huang Q, Gu L, Wang H. PMID: 42240729 [PubMed - as supplied by publisher]
	Early vs. delayed primary local therapy and survival in de novo metastatic prostate cancer: target trial emulation. World J Urol Hassan AA, Aboelsaad AY, Gawad AMA, El-Dydamony EM, Algammal MI, Abdel-Al I, Koritenah AK, Abuelazayem TM, Salman MF, El-Wahsh AF, Ali MM, Shouman HA, Hindawy MA, Deif H, Wasfy IS. PMID: 42240667 [PubMed - in process]
	Image-guided percutaneous ablation techniques for the treatment of renal cell carcinoma: a primer for radiologists. Abdom Radiol (NY) Hernández-Mancera J, Remer EM, Graumann O, Borgbjerg J. PMID: 42240648 [PubMed - as supplied by publisher]

Articles 1 - 20 / 178733

Page 1 of 8937



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy